SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029495
Filing Date
2022-08-15
Accepted
2022-08-15 17:01:26
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acer-10q_20220630.htm   iXBRL 10-Q 2547067
2 EX-31.1 acer-ex311_7.htm EX-31.1 17674
3 EX-31.2 acer-ex312_8.htm EX-31.2 17685
4 EX-32.1 acer-ex321_6.htm EX-32.1 7887
5 EX-32.2 acer-ex322_9.htm EX-32.2 7471
6 GRAPHIC g14a0wkan1mv000001.jpg GRAPHIC 17440
  Complete submission text file 0001564590-22-029495.txt   9363790

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA acer-20220630.xsd EX-101.SCH 68265
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acer-20220630_cal.xml EX-101.CAL 42354
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acer-20220630_def.xml EX-101.DEF 271405
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20220630_lab.xml EX-101.LAB 516100
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20220630_pre.xml EX-101.PRE 423295
57 EXTRACTED XBRL INSTANCE DOCUMENT acer-10q_20220630_htm.xml XML 1455881
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 221166490
SIC: 2834 Pharmaceutical Preparations